title: Intermittent medication for schizophrenic outpatients: who is eligible?
abstract: The Medication Clinic of a large, urban Mental Health Center was screened for schizophrenic patients eligible for an intermittent medication approach. A total of 112 patients were evaluated, and 39, or 34.8 percent of the sample, met our basic inclusion criteria. No sex or age differences were found for eligibility. Sufficient eligible patients were found to make the intermittent medication approach a useful part of a comprehensive psychopharmacological program for schizophrenia, if the efficacy of the approach is demonstrated in clinical trials.
authors.affiliation: Harborview Community Mental Health Center, Dept. of Psychiatry and Behavioral Sciences, University of Washington, Seattle 98195.
authors.forename: J A
authors.initials: JA
authors.lastname: Chiles
authors.forename: D
authors.initials: D
authors.lastname: Sterchi
authors.forename: T
authors.initials: T
authors.lastname: Hyde
authors.forename: M I
authors.initials: MI
authors.lastname: Herz
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents